The TIC10 Structural Paradox: A Landmark Ruling on Patent Enablement
Tina Micksch 18. May 2026
In a pivotal decision (3 Ni 6/24 (EP)), the German Federal Patent Court (BPatG) invalidated a patent for a cancer therapy due to a “structural
Blog posts
Tag: PatentLaw
Results of you search request.
Results of you search request.
Weiterlesen »
Patent Law Update: BGH Decision “Fructose Intolerance” – No Room for Speculation in Medical Use Patents?
Tina Micksch 27. April 2026
The German Federal Court of Justice (BGH) recently issued a landmark decision (X ZB 3/25) on February 25, 2026, clarifying the requirements for the disclosure
Landmark BGH Decision on Fampridine-SR: New Standards for Novelty and “Reasonable Expectation of Success” in Pharma Patents
Tina Micksch 24. April 2026
The German Federal Court of Justice (BGH) has recently overturned a lower court decision, confirming the validity of a patent for Fampridine-SR used to increase
Major Win for MedTech Innovation: German Federal Court of Justice Interprets Diagnostic Exclusion Narrowly!
Tina Micksch 2. April 2026
Great news for the Digital Health sector and developers of AI-supported diagnostic systems! In a recent landmark decision (X ZB 5/25), the German Federal Court
Contact
+49 351 470 37 - 0
info@ku-patent.de
https://ku-patent.de/
Kailuweit & Uhlemann | Patentanwälte
Partnerschaft mbB
Office location:
Bamberger Straße 49
01187 Dresden
Branch offices:
Leuchtenfabrik, Edisonstraße 63
House A, 1st floor
12459 Berlin
Ferdinand-Lassalle-Straße 16
04109 Leipzig
Feringastraße 6, 3rd floor
85774 München-Unterföhring
Töpferstraße 39
02625 Bautzen/Budyšin
Central postal address:
Postfach 32 01 39
01013 Dresden
Germany